Arena Pharmaceuticals Gets FDA's OK For Obesity Drug

Published on June 28 2012 by topnewsrom

(By Rich Bieglmeier) Arena Pharmaceuticals, Inc. (ARNA) obesity drug, now called Belviq (formerly known as lorcaserin) has been Okayed by an 18-4 vote. It is the first new obesity drug to hit the market in 13 years. The stock

(HALTED). Written on June 27, 2012 by gem-x in Elliott Wave Intraday – 12:23 pm. http://finance.yahoo.com/news/arena-pharmaceuticals-confirms-fda-approval-171615365.html. 0 Comments – Leave a comment! – - 12:23 pm

News that the Food & Drug Administration has approved Arena Pharmaceuticals (NASDAQ: ARNA ) weight-loss pill Lorcaserin is proving.

Arena Pharmaceuticals Gets FDA's OK For Obesity Drug

Arena Wins FDA Advisory Panel Backing for Obesity Pill Trading in shares of Beacon Roofing Supply Inc. (BECN: News ) was halted. The company swung to a profit in its second quarter. Sales rose 33 percent, and were notable above Wall Street view. Trading ...
FDA panel favors Pfizer’s new arthritis drug Federal health advisers said Wednesday that a first-of-a-kind drug from Pfizer appears to be safe and effective for patients with rheumatoid arthritis, though they recommended follow-up studies to gauge the pill's long-term side effects.
Everything’s on table in fight against obesity
Research May Point to New Obesity Treatments
Obesity fight must shift from personal blame: U.S. panel
FDA: Kids’ medical tests need child-size radiation The government is taking steps to help ensure that children who need CT scans and other X-ray-based tests don't get an adult-sized dose of radiation.
Indian drug giant Cipla slashes cancer drug prices
« Legend of Korra